Erlotinib Completed Phase 1 / 2 Trials for NSCLC (Advanced Non-small Cell Lung Cancer) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs